Genmab A/S (GMAB)
27.05
-0.43
(-1.56%)
USD |
NASDAQ |
Mar 06, 16:00
27.05
0.00 (0.00%)
After-Hours: 18:33
Genmab Cash from Investing (TTM) : -5.660B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| AbbVie, Inc. | -6.643B |
| Novo Nordisk A/S | -12.02B |
| Krystal Biotech, Inc. | -58.42M |
| Ascendis Pharma A/S | -9.612M |
| Zealand Pharma A/S | -350.42M |